Filing Flows › Sanuwave Health (SNWV) › Capital expenditures
Sanuwave Health (SNWV) capital expenditures by quarter
Sanuwave Health's capital expenditures were $334K in Q2 2026 (second quarter 2026), up 15-fold from Q1 2026. Over the last 6 quarters it ranged from $23K (Q1 2026) to $1.2M (Q2 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $334K | 15× | -71% |
| Q1 2026 | $23K | -76% | — |
| Q4 2025 | $96K | -82% | -59% |
| Q3 2025 | $525K | -55% | — |
| Q2 2025 | $1.2M | +391% | — |
| Q4 2024 | $236K | — | — |
Q2 2026 at a glance
Sanuwave Health, Q2 2026: revenue $9.7M (-3% year over year), operating margin -2.9%, net loss $682K, operating cash flow $425K. The chart follows the revenue to costs, profit and cash.
Questions
What is Sanuwave Health's capital expenditures?
Sanuwave Health's capital expenditures were $334K in Q2 2026 (second quarter 2026), up 15-fold from Q1 2026.
How has Sanuwave Health's capital expenditures changed?
Over the last 6 quarters it ranged from $23K (Q1 2026) to $1.2M (Q2 2025).